ALA ASX · Health Care

Arovella Therapeutics Ltd

Announcements, last 12 months: 81
Price sensitive, last 12 months: 15
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 8:27 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
22 Oct 2026, 8:43 AM	Arovella receives R&D tax rebate of $4.03 million Price sensitive	AI summary
7 Oct 2026, 8:57 AM	Second Clinical Batch Released for Immediate Patient Use Price sensitive	AI summary
6 Oct 2026, 4:55 PM	Cell and Gene Innovation Spotlight Presentation
5 Oct 2026, 8:20 AM	Notice of Annual General Meeting/Proxy Form
1 Oct 2026, 1:54 PM	The path to first patient dosing Price sensitive	AI summary
17 Sep 2026, 8:56 AM	2026 ESG Report
9 Sep 2026, 8:21 AM	Notification of 2026 AGM Date
7 Sep 2026, 9:00 AM	Clinical manufacturing batch released, first site activated Price sensitive	AI summary
20 Aug 2026, 11:31 AM	Corporate Governance Statement

Sign in to see all ALA announcements.

Guidance history

22 Oct 2026

None

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow ALA to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.